{"cik":"0001672619","ticker":"ELVN","name":"Enliven Therapeutics, Inc.","sic_code":null,"sic_description":null,"exchange":"Nasdaq","state_of_incorporation":null,"fiscal_year_end":null,"first_filing_date":"2026-04-27","last_filing_date":"2026-04-27","url":"/sec/cik-0001672619","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0001193125-26-182081","form_type":"DEFA14A","form_type_family":"proxy","doc_date":"2026-04-27","title":"DEFA14A — Enliven Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001672619/defa14a/0001193125-26-182081","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001193125-26-182081-index.html"},{"accession_number":"0001193125-26-182045","form_type":"DEF 14A","form_type_family":"proxy","doc_date":"2026-04-27","title":"DEF 14A — Enliven Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001672619/def-14a/0001193125-26-182045","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001193125-26-182045-index.html"},{"accession_number":"0001193125-26-182102","form_type":"ARS","form_type_family":"other","doc_date":"2026-04-27","title":"ARS — Enliven Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001672619/ars/0001193125-26-182102","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672619/0001193125-26-182102-index.html"}],"related_endpoints":{"profile":"/sec/ELVN/profile","timeline":"/sec/ELVN/timeline","peers":"/sec/ELVN/peers","insider_pulse":"/sec/ELVN/insider-pulse","insider_summary":"/sec/ELVN/insider-summary","insider_transactions":"/sec/ELVN/insider-transactions","form144":"/sec/ELVN/form144","holdings_as_filer":"/sec/ELVN/holdings","financial_facts":"/sec/ELVN/financial-facts","derivatives":"/sec/ELVN/derivatives","officers":"/sec/ELVN/officers","insider_network":"/sec/ELVN/insider-network","risk_flags":"/sec/ELVN/risk-flags","filings":"/sec/ELVN/filings","cross_topic_dossier":"/api/v1/dossier?ticker=ELVN"}}